The Oncosearch | Oncotarget

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine Review

Paola Rossi, Raffaele Difrancia, Vincenzo Quagliariello, Elena Savino, Paolo Tralongo, Cinzia Lucia Randazzo, Massimiliano Berretta

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24837-24856

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Guillemette Fouquet, StÃ©phanie Guidez, Valentine Richez, Anne-Marie Stoppa, Christophe Le Tourneau, Margaret Macro, CÃ©cile Gruchet, Arthur Bobin, Niels Moya, Thomas Systchenko, Florence Sabirou, Anthony Levy, Paul Franques, HÃ©lÃ¨ne Gardeney, Lionel Karlin, Lotfi Benboubker, Monia Ouali, Jean-Claude Vedovato, Pierre Ferre, Mariya Pavlyuk, Michel Attal, Thierry Facon, Xavier Leleu

Published May 8, 2018 · Vol. 9, No. 35 · pp. 23890-23899

Oridonin inhibits aberrant AKT activation in breast cancer Research Paper

Bowen Sun, Geng Wang, Huidong Liu, Pian Liu, Waleed O. Twal, Hiuwing Cheung, Steven L. Carroll, Stephen P. Ethier, Emily E. Mevers, Jon Clardy, Thomas Roberts, Changbin Chen, Qian Li, Lanfeng Wang, Meixiang Yang, Jean J. Zhao, Qi Wang

Published May 8, 2018 · Vol. 9, No. 35 · pp. 23878-23889

Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients Research Paper

JosÃ© MarÃa SayaguÃ©s, SofÃa Del Carmen, MarÃa Del Mar Abad, LuÃs Antonio Corchete, Oscar Bengoechea, MarÃa Fernanda Anduaga, MarÃa JesÃºs BaldeÃ³n, Juan JesÃºs Cruz, Jose Antonio Alcazar, MarÃa Angoso, Marcos GonzÃ¡lez, Jacinto GarcÃa, LuÃs MuÃ±oz-Bellvis, Alberto Orfao, MarÃa Eugenia Sarasquete

Published May 8, 2018 · Vol. 9, No. 35 · pp. 24081-24096

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study Clinical Research Papers

Yutaka Fujiwara, Masayuki Takeda, Noboru Yamamoto, Kazuhiko Nakagawa, Kaname Nosaki, Ryo Toyozawa, Chihiro Abe, Ryota Shiga, Kenji Nakamaru, Takashi Seto

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23729-23737

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

Alessandro Broccoli, Beatrice Casadei, Alice Morigi, Federico Sottotetti, Manuel Gotti, Michele Spina, Stefano Volpetti, Simone Ferrero, Francesco Spina, Francesco Pisani, Michele Merli, Carlo Visco, Rossella Paolini, Vittorio Ruggero Zilioli, Luca Baldini, Nicola Di Renzo, Patrizia Tosi, Nicola Cascavilla, Stefano Molica, Fiorella Ilariucci, Gian Matteo Rigolin, Francesco D'AlÃ², Anna Vanazzi, Elisa Santambrogio, Roberto Marasca, Lucia Mastrullo, Claudia Castellino, Giovanni Desabbata, Ilaria Scortechini, Livio Trentin, Lucia Morello, Lisa Argnani, Pier Luigi Zinzani

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23443-23450

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacyâ€”a single center experience Research Paper

Alexandre Arsene-Henry, Jean-Philippe Foy, Magalie Robilliard, Hao-Ping Xu, Louis Bazire, Dominique Peurien, Philip Poortmans, Alain Fourquet, Youlia M. Kirova

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23608-23619

Pilot study of dovitinib in patients with von Hippel-Lindau disease Research Paper

Patrick PiliÃ©, Elshad Hasanov, Surena F. Matin, Ashley H. Henriksen Woodson, Valerie D. Marcott, Shelly Bird, Rebecca S. Slack, Gregory N. Fuller, Ian E. McCutcheon, Eric Jonasch

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23390-23395

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Colm Keane, Joshua Tobin, Dipti Talaulikar, Michael Green, Pauline Crooks, Sanjiv Jain, Maher Gandhi

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23620-23627

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer Meta-Analysis

Rubens Barros Costa, Ricardo L.B. Costa, Sarah M. Talamantes, Jason B. Kaplan, Manali A. Bhave, Alfred Rademaker, Corinne Miller, Benedito A. Carneiro, Devalingam Mahalingam, Young Kwang Chae

Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 22137-22146

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy Research Paper

Giacomo Quattrocchio, Antonella Barreca, Andrea Demarchi, Laura Solfietti, Giulietta Beltrame, Roberta Fenoglio, Michela Ferro, Paola Mesiano, Stefano Murgia, Giulio Del Vecchio, Carlo Massara, Cristiana Rollino, Dario Roccatello

Published Apr 20, 2018 · Vol. 9, No. 30 · pp. 21337-21347

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy Research Paper

Bushra Weidenbusch, GÃ¼nther H.S. Richter, Marie Sophie Kesper, Monika Guggemoos, Katja Gall, Carolin Prexler, Ilya Kazantsev, Alexandra Sipol, Lars Lindner, Michaela Nathrath, Olaf Witt, Katja Specht, Frigga Beitinger, Carolin Knebel, Stuart Hosie, RÃ¼diger von Eisenhardt-Rothe, Wilko Weichert, Irene Teichert-von Luettichau, Stefan Burdach

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20747-20760

Hypertension in malignancyâ€“an underappreciated problem Review

Jolanta MaÅ‚yszko, Maciej MaÅ‚yszko, Leszek Kozlowski, Klaudia Kozlowska, Jacek MaÅ‚yszko

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20855-20871

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy Research Paper

Dina MÃ¶nch, Sabine Bode-Erdmann, JÃ¶rg Kalla, JÃ¶rn StrÃ¤ter, Carsten SchwÃ¤nen, Roger Falkenstern-Ge, Siegfried Klumpp, Godehard Friedel, German Ott, Claudia Kalla

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20781-20794

Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy Research Paper

YunLong Zhang, Shuangfei Hu, Hongfa Wang, Fang Cai, Sheliang Shen, Xiaopan Luo

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20294-20303

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma Research Paper

Hanno Witte, Harald Biersack, Svenja Kopelke, Dirk Rades, Hartmut Merz, Veronica Bernard, Hendrik Lehnert, Niklas Gebauer

Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19613-19622

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment Clinical Research Papers

Katsunori Tatsugami, Mototsugu Oya, Koki Kabu, Hideyuki Akaza

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19406-19414

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, Masato Nakamura, Hiroshi Nakayama, Manabu Shiozawa, Akitaka Makiyama, Kazuma Kobayashi, Yutaro Kubota, Misuzu Mori, Masahito Kotaka, Akinori Takagane, Masahiro Gotoh, Masahiro Takeuchi, Masashi Fujii, Wararu Ichikawa, Takashi Sekikawa

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18811-18820

Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study Research Paper

Tzung-Yi Tsai, Tsung-Hsing Hung, Hanoch Livneh, I-Hsin Lin, Ming-Chi Lu, Chia-Chou Yeh

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18214-18223

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging Research Paper

Meiko Nishimura, Mitsuhiro Hayashi, Yu Mizutani, Kei Takenaka, Yoshinori Imamura, Naoko Chayahara, Masanori Toyoda, Naomi Kiyota, Toru Mukohara, Hiroaki Aikawa, Yasuhiro Fujiwara, Akinobu Hamada, Hironobu Minami

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18540-18547

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine Review

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Oridonin inhibits aberrant AKT activation in breast cancer Research Paper

Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients Research Paper

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study Clinical Research Papers

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacyâ€”a single center experience Research Paper

Pilot study of dovitinib in patients with von Hippel-Lindau disease Research Paper

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer Meta-Analysis

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy Research Paper

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy Research Paper

Hypertension in malignancyâ€“an underappreciated problem Review

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy Research Paper

Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy Research Paper

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma Research Paper

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment Clinical Research Papers

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study Research Paper

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine Review

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Oridonin inhibits aberrant AKT activation in breast cancer Research Paper

Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients Research Paper

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study Clinical Research Papers

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacyâ€”a single center experience Research Paper

Pilot study of dovitinib in patients with von Hippel-Lindau disease Research Paper

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer Meta-Analysis

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy Research Paper

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy Research Paper

Hypertension in malignancyâ€“an underappreciated problem Review

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy Research Paper

Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy Research Paper

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma Research Paper

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment Clinical Research Papers

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study Research Paper

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging Research Paper